Drug Trial Radar · NCT06771219
SLV-154 Treatment of Advanced Cancers
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
May 14, 2025
Primary completion
Aug 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Solve TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 13, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1 study comprising a Phase 1a dose-escalation portion and a Phase 1b expansion portion evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with advanced solid tumors.
Conditions
- Advanced Cancer
- Advanced Solid Tumor
- Metastatic Cancer
Interventions
SLV-154Drug
SLV-154
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1a: MTD and/or RDRTime frame: Through the duration of treatment, up to approximately 18 months
- Phase 1b: Objective response rate (ORR)Time frame: Through the duration of treatment, up to approximately 18 months
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Precision NextGen Oncology and Research Center
Beverly Hills, California · Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach, California · Recruiting
Sarcoma Oncology Research Center
Santa Monica, California · Recruiting
Washington University
St Louis, Missouri · Recruiting
Astera Cancer Care
East Brunswick, New Jersey · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Recruiting
The James Outpatient Care West Center
Columbus, Ohio · Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
Oncology Consultants
Houston, Texas · Recruiting
Mays Cancer Center; University of Texas Health San Antonio
San Antonio, Texas · Recruiting
University of Washington / Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Northwest Medical Specialties, PLLC
Tacoma, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.